Wealth Enhancement Advisory Services, LLC Abb Vie Inc. Put Options Transaction History

Wealth Enhancement Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $2.11 Million - $2.57 Million	12,900 Added 3225.0%	13,300 $2.63 Million
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $1.8 Million - $2.1 Million	-11,600 Reduced 96.67%	400 $68,000
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $207,766 - $236,730	-1,300 Reduced 9.77%	12,000 $2.19 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $1.78 Million - $2.06 Million	13,300 New	13,300 $1.98 Million

3,846

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.